- Home
- QNST vs KURA Comparison
QNST vs KURA Comparison
Compare QNST & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QNST | KURA |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 870.0M | 830.1M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | QNST | KURA |
|---|---|---|
| Price | $14.45 | $9.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 10 |
| Target Price | $24.75 | ★ $26.88 |
| AVG Volume (30 Days) | 515.3K | ★ 1.7M |
| Earning Date | 02-05-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $1,100,345,000.00 | $104,029,000.00 |
| Revenue This Year | $11.73 | $138.16 |
| Revenue Next Year | $12.19 | $66.98 |
| P/E Ratio | $84.26 | ★ N/A |
| Revenue Growth | ★ 43.12 | N/A |
| 52 Week Low | $12.98 | $5.41 |
| 52 Week High | $25.50 | $12.49 |
Technical Indicators
Market Signals| Indicator | QNST | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 45.71 | 39.65 |
| Support Level | $14.80 | $8.92 |
| Resistance Level | $15.29 | $10.40 |
| Average True Range (ATR) | 0.59 | 0.46 |
| MACD | -0.00 | -0.10 |
| Stochastic Oscillator | 19.87 | 18.06 |
Price Performance
Historical ComparisonAbout QNST QuinStreet Inc.
QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. Its products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and CloudControlMedia. Geographically, it operates in United States and Internationally, of which maximum revenue is derived from United States.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.